Loading…
Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic
•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures. This review considers the impact of the SARS-CoV-2 pan...
Saved in:
| Published in: | Diabetes research and clinical practice 2022-03, Vol.185, p.109777-109777, Article 109777 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3 |
| container_end_page | 109777 |
| container_issue | |
| container_start_page | 109777 |
| container_title | Diabetes research and clinical practice |
| container_volume | 185 |
| creator | Sathyanarayanan, A. Crabtree, T. Choudhary, P. Elliott, J. Evans, M.L. Lumb, A. Wilmot, E.G. |
| description | •This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures.
This review considers the impact of the SARS-CoV-2 pandemic on access to interventions for those living with type 1 diabetes and discusses the solutions which have been considered and actioned to ensure ongoing access care.
We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published.
Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. The SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these intervention. Multiple adaptations have been put in place – transition to online delivery of education and care, and usage of diabetes technology.
Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them. |
| doi_str_mv | 10.1016/j.diabres.2022.109777 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8831709</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822722005897</els_id><sourcerecordid>2629057484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEokPhEUBessngOI5_NqDR8CsqIVHK1nLs69ajTBzsJFV37FnyhjwJTmeoYMXKlv2dc-x7iuJphdcVrtiL3dp63UZIa4IJyWeSc36vWFWCk1IQwu8Xq8yJ2_1J8SilHcaY1bR5WJzUTdVwSetV8eM1dH6G6PtLBLO30BsoW53AIt-PEGfoRx_6hFyIaLwZAFVoCYYRUibQeAVo9nGcdIeuQ-ws-vX9J9qgmM3gGgWHLj6iIWozegPITrdBi-h88_m83IavJUGD7i3svXlcPHC6S_DkuJ4WF2_ffNm-L88-vfuw3ZyVhjI-lpJaSUG2DaOSCm0bJ5lopQTMGKWEWVoBdg3XHDDWlFLnKNEMO1EL7SpbnxYvD77D1O7BmvzFqDs1RL_X8UYF7dW_N72_UpdhVkLUFccyGzw_GsTwbYI0qr1PBrpO9xCmpAgjEjecCprR5oCaGFKK4O5iKqyWItVOHYtUS5HqUGTWPfv7jXeqP81l4NUBgDypPOuokvFLe9ZHMKOywf8n4jerA7QP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2629057484</pqid></control><display><type>article</type><title>Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic</title><source>ScienceDirect Freedom Collection</source><creator>Sathyanarayanan, A. ; Crabtree, T. ; Choudhary, P. ; Elliott, J. ; Evans, M.L. ; Lumb, A. ; Wilmot, E.G.</creator><creatorcontrib>Sathyanarayanan, A. ; Crabtree, T. ; Choudhary, P. ; Elliott, J. ; Evans, M.L. ; Lumb, A. ; Wilmot, E.G.</creatorcontrib><description>•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures.
This review considers the impact of the SARS-CoV-2 pandemic on access to interventions for those living with type 1 diabetes and discusses the solutions which have been considered and actioned to ensure ongoing access care.
We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published.
Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. The SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these intervention. Multiple adaptations have been put in place – transition to online delivery of education and care, and usage of diabetes technology.
Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2022.109777</identifier><identifier>PMID: 35157943</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Blood Glucose ; Blood Glucose Self-Monitoring ; COVID-19 - epidemiology ; Diabetes Mellitus ; Diabetes Mellitus, Type 1 - epidemiology ; Diabetes Mellitus, Type 1 - therapy ; Digital Divide ; Evidence-Based Medicine ; Humans ; Pandemics - prevention & control ; Quality of Life ; Remote Consultation ; SARS-CoV-2 ; Type 1 ; United Kingdom - epidemiology</subject><ispartof>Diabetes research and clinical practice, 2022-03, Vol.185, p.109777-109777, Article 109777</ispartof><rights>2022</rights><rights>Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.</rights><rights>Crown Copyright © 2022 Published by Elsevier B.V. All rights reserved. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3</citedby><cites>FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35157943$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sathyanarayanan, A.</creatorcontrib><creatorcontrib>Crabtree, T.</creatorcontrib><creatorcontrib>Choudhary, P.</creatorcontrib><creatorcontrib>Elliott, J.</creatorcontrib><creatorcontrib>Evans, M.L.</creatorcontrib><creatorcontrib>Lumb, A.</creatorcontrib><creatorcontrib>Wilmot, E.G.</creatorcontrib><title>Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures.
This review considers the impact of the SARS-CoV-2 pandemic on access to interventions for those living with type 1 diabetes and discusses the solutions which have been considered and actioned to ensure ongoing access care.
We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published.
Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. The SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these intervention. Multiple adaptations have been put in place – transition to online delivery of education and care, and usage of diabetes technology.
Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them.</description><subject>Blood Glucose</subject><subject>Blood Glucose Self-Monitoring</subject><subject>COVID-19 - epidemiology</subject><subject>Diabetes Mellitus</subject><subject>Diabetes Mellitus, Type 1 - epidemiology</subject><subject>Diabetes Mellitus, Type 1 - therapy</subject><subject>Digital Divide</subject><subject>Evidence-Based Medicine</subject><subject>Humans</subject><subject>Pandemics - prevention & control</subject><subject>Quality of Life</subject><subject>Remote Consultation</subject><subject>SARS-CoV-2</subject><subject>Type 1</subject><subject>United Kingdom - epidemiology</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhSMEokPhEUBessngOI5_NqDR8CsqIVHK1nLs69ajTBzsJFV37FnyhjwJTmeoYMXKlv2dc-x7iuJphdcVrtiL3dp63UZIa4IJyWeSc36vWFWCk1IQwu8Xq8yJ2_1J8SilHcaY1bR5WJzUTdVwSetV8eM1dH6G6PtLBLO30BsoW53AIt-PEGfoRx_6hFyIaLwZAFVoCYYRUibQeAVo9nGcdIeuQ-ws-vX9J9qgmM3gGgWHLj6iIWozegPITrdBi-h88_m83IavJUGD7i3svXlcPHC6S_DkuJ4WF2_ffNm-L88-vfuw3ZyVhjI-lpJaSUG2DaOSCm0bJ5lopQTMGKWEWVoBdg3XHDDWlFLnKNEMO1EL7SpbnxYvD77D1O7BmvzFqDs1RL_X8UYF7dW_N72_UpdhVkLUFccyGzw_GsTwbYI0qr1PBrpO9xCmpAgjEjecCprR5oCaGFKK4O5iKqyWItVOHYtUS5HqUGTWPfv7jXeqP81l4NUBgDypPOuokvFLe9ZHMKOywf8n4jerA7QP</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Sathyanarayanan, A.</creator><creator>Crabtree, T.</creator><creator>Choudhary, P.</creator><creator>Elliott, J.</creator><creator>Evans, M.L.</creator><creator>Lumb, A.</creator><creator>Wilmot, E.G.</creator><general>Elsevier B.V</general><general>Published by Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220301</creationdate><title>Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic</title><author>Sathyanarayanan, A. ; Crabtree, T. ; Choudhary, P. ; Elliott, J. ; Evans, M.L. ; Lumb, A. ; Wilmot, E.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Blood Glucose</topic><topic>Blood Glucose Self-Monitoring</topic><topic>COVID-19 - epidemiology</topic><topic>Diabetes Mellitus</topic><topic>Diabetes Mellitus, Type 1 - epidemiology</topic><topic>Diabetes Mellitus, Type 1 - therapy</topic><topic>Digital Divide</topic><topic>Evidence-Based Medicine</topic><topic>Humans</topic><topic>Pandemics - prevention & control</topic><topic>Quality of Life</topic><topic>Remote Consultation</topic><topic>SARS-CoV-2</topic><topic>Type 1</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sathyanarayanan, A.</creatorcontrib><creatorcontrib>Crabtree, T.</creatorcontrib><creatorcontrib>Choudhary, P.</creatorcontrib><creatorcontrib>Elliott, J.</creatorcontrib><creatorcontrib>Evans, M.L.</creatorcontrib><creatorcontrib>Lumb, A.</creatorcontrib><creatorcontrib>Wilmot, E.G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sathyanarayanan, A.</au><au>Crabtree, T.</au><au>Choudhary, P.</au><au>Elliott, J.</au><au>Evans, M.L.</au><au>Lumb, A.</au><au>Wilmot, E.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>185</volume><spage>109777</spage><epage>109777</epage><pages>109777-109777</pages><artnum>109777</artnum><issn>0168-8227</issn><eissn>1872-8227</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>ObjectType-Review-1</notes><abstract>•This review summarises the impact of SARS-CoV-2 on interventions for type 1 diabetes in the UK.•The COVID-19 pandemic may shape the future of diabetes care forever.•The widening technological inequity needs resolution through targeted measures.
This review considers the impact of the SARS-CoV-2 pandemic on access to interventions for those living with type 1 diabetes and discusses the solutions which have been considered and actioned to ensure ongoing access care.
We performed a focussed review of the published literature, and the guidelines for changes that have been effected during the pandemic. We also drew from expert recommendations and information about local practice changes for areas where formal data have not been published.
Evidence based interventions which support the achievement of improved glucose levels and/or reduction in hypoglycaemia include group structured education to support self-management, insulin pump therapy and continuous glucose monitoring. The SARS-CoV-2 pandemic had impacted the ability of diabetes services to deliver these intervention. Multiple adaptations have been put in place – transition to online delivery of education and care, and usage of diabetes technology.
Although various adaptations have been made during the pandemic that have positively influenced uptake of services, there are many areas of delivery that need immediate improvement in the UK. We recommend a proactive approach in recognising the digital divide and inequity in distribution of these changes and we recommend introducing measures to reduce them.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>35157943</pmid><doi>10.1016/j.diabres.2022.109777</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8227 |
| ispartof | Diabetes research and clinical practice, 2022-03, Vol.185, p.109777-109777, Article 109777 |
| issn | 0168-8227 1872-8227 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8831709 |
| source | ScienceDirect Freedom Collection |
| subjects | Blood Glucose Blood Glucose Self-Monitoring COVID-19 - epidemiology Diabetes Mellitus Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 1 - therapy Digital Divide Evidence-Based Medicine Humans Pandemics - prevention & control Quality of Life Remote Consultation SARS-CoV-2 Type 1 United Kingdom - epidemiology |
| title | Delivering evidence-based interventions for type 1 diabetes in the virtual world – A review of UK practice during the SARS-CoV-2 pandemic |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T06%3A29%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Delivering%20evidence-based%20interventions%20for%20type%201%20diabetes%20in%20the%20virtual%20world%20%E2%80%93%20A%20review%20of%20UK%20practice%20during%20the%20SARS-CoV-2%20pandemic&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Sathyanarayanan,%20A.&rft.date=2022-03-01&rft.volume=185&rft.spage=109777&rft.epage=109777&rft.pages=109777-109777&rft.artnum=109777&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2022.109777&rft_dat=%3Cproquest_pubme%3E2629057484%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-94d94e9b564948ad5f968b99e0664426d41e0f57a7e00a444ff42a60f838af1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2629057484&rft_id=info:pmid/35157943&rfr_iscdi=true |